| Name | 5-Amino-4,6-dichloropyrimidine |
|---|---|
| Synonyms |
4,6-dichloro-5-pyrimidinamin
5-AMINO-4,6-DICHLOROPYFIMIDINE Pyrimidine, 5-amino-4,6-dichloro- 5-Amino-4,6-dichloro 5-Pyrimidinamine, 4,6-dichloro- 4,6-Dichloro-5-aminopyrimidine 5-Amino-4,6-dichloropyrimidine 4,6-Dichloro-5-pyrimidinamine 4,6-dichloropyrimidin-5-amine 5-AMino-4 4,6-dichloropyrimidine-5-amine MFCD00006108 5-amino-4,6-dichloropyrimididne EINECS 226-503-7 5-amino-4,6-dichloro-pyrimidine 5-amino-4,6-dichloro-4-pyrimidine |
| Description | 4,6-Dichloropyrimidin-5-amine is a biochemical reagent that can be used as a biological material or organic compound for life science related research. |
|---|---|
| Related Catalog |
| Density | 1.6±0.1 g/cm3 |
|---|---|
| Boiling Point | 267.1±35.0 °C at 760 mmHg |
| Melting Point | 145-148 °C(lit.) |
| Molecular Formula | C4H3Cl2N3 |
| Molecular Weight | 163.99 |
| Flash Point | 115.3±25.9 °C |
| Exact Mass | 162.970398 |
| PSA | 51.80000 |
| LogP | 1.81 |
| Vapour Pressure | 0.0±0.5 mmHg at 25°C |
| Index of Refraction | 1.633 |
| Storage condition | 2-8°C |
| Water Solubility | slightly soluble |
| Symbol |
GHS07 |
|---|---|
| Signal Word | Warning |
| Hazard Statements | H315-H319-H335 |
| Precautionary Statements | P261-P305 + P351 + P338 |
| Personal Protective Equipment | dust mask type N95 (US);Eyeshields;Gloves |
| Hazard Codes | Xi: Irritant; |
| Risk Phrases | R36/37/38 |
| Safety Phrases | S26-S36-S24/25 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | 3 |
| HS Code | 29335995 |
|
~98%
5413-85-4 |
| Literature: Latli, Bachir; Jones, Paul-James; Krishnamurthy, Dhileepkumar; Senanayake, Chris H. Journal of Labelled Compounds and Radiopharmaceuticals, 2008 , vol. 51, # 1 p. 54 - 58 |
|
~%
5413-85-4 |
| Literature: ENANTIA, S.L.; PASTÓ AGUILÀ, Mireia; COMELY, Alexander Christian Patent: WO2014/23681 A1, 2014 ; Location in patent: Page/Page column 33; 34 ; |
| Precursor 2 | |
|---|---|
| DownStream 10 | |
| HS Code | 2933599090 |
|---|---|
| Summary | 2933599090. other compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |